secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001356576-24-000069
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus updates Code of Ethics and Business Conduct on Dec 19, 2024
--------------------------------------------------------------------

- Board of Directors approved an updated Code of Ethics and Business Conduct on December 19, 2024.
- Updates clarify reporting channels, consequences for violations, conflicts of interest, and compliance guidance.
- No waivers or implicit waivers were granted; code will be posted on the Investor Relations website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657624000069/0001356576-24-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657624000069/supn-20241219.htm
  HTML page:      https://secwatch.observer/filing/0001356576-24-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer